Last10K.com

Carefusion Corp (CFN) SEC Filing 10-Q Quarterly report for the period ending Wednesday, December 31, 2014

Carefusion Corp

CIK: 1457543 Ticker: CFN
Exhibit 99.1
            
3750 Torrey View Ct
San Diego, CA 92130
www.carefusion.com


FOR IMMEDIATE RELEASE

Contacts:
Media: Kristen Cardillo
              (858) 617-2317
              kristen.cardillo@carefusion.com
Investors: Jim Mazzola
(858) 617-1203
jim.mazzola@carefusion.com

CAREFUSION REPORTS SECOND QUARTER FISCAL 2015 RESULTS

Revenue increased 16 percent to $1.07 billion

GAAP diluted earnings per share (EPS) from continuing operations totaled $0.83 and increased 83 percent from the prior year period to $0.99 on an adjusted basis

Planned merger with Becton, Dickinson and Company (BD) expected to close by March 31

SAN DIEGO, Feb. 5, 2015 - CareFusion Corp. (NYSE: CFN), a leading, global medical technology company, today reported financial results for its fiscal second quarter, growing revenue in every business line and major geography and increasing adjusted EPS by 83 percent from the prior year period.
“Our team remained disciplined in their execution and saw the benefit from investments we’ve made during the past four years, with record quarterly results across the company,” said Kieran T. Gallahue, chairman and CEO. “In what will likely be the last reported quarter before our merger with BD, we have good momentum in all businesses, our customers see clear value in what we offer today and we have an even stronger vision for the future as part of BD.
“Results in the Medical Systems segment were again highlighted by the strength of our medication management offering, anchored by another quarter of strong committed contracts for our industry leading Pyxis® dispensing technologies and Alaris® infusion systems. In the Procedural Solutions segment, we continued to grow faster than the market due to the strength of our clinically differentiated products and the impact of our Vital Signs acquisition. Outside the U.S. - where we have been actively refining our offerings and go-to-market models -- we recorded double-digit revenue growth in Europe, Asia, Canada and Latin America.


The following information was filed by Carefusion Corp (CFN) on Thursday, February 5, 2015 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.

View differences made from one quarter to another to evaluate Carefusion Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Carefusion Corp.

Continue

Assess how Carefusion Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Carefusion Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2015 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Document And Entity Information
Condensed Consolidated Balance Sheets
Condensed Consolidated Balance Sheets (parenthetical)
Condensed Consolidated Statements Of Cash Flows
Condensed Consolidated Statements Of Income
Statement Of Comprehensive Income Statement
Basis Of Presentation
Basis Of Presentation (policies)
Basis Of Presentation Basis Of Presentation (details)
Borrowings
Borrowings (narrative) (details)
Borrowings (schedule Of Debt) (details)
Borrowings (schedule Of Line Of Credit) (details)
Borrowings (schedule Of Other Short-term Borrowings) (details)
Business Combinations (notes)
Business Combinations (schedule Of Business Acquisitions) (details)
Business Combinations (schedule Of Intangible Assets Acquired) (details)
Business Combinations (tables)
Commitments And Contingencies
Commitments And Contingencies (details)
Commitments And Contingencies Commitments And Contingencies (narrative) (details)
Earnings Per Share (notes)
Earnings Per Share (reconciliation Of Basic And Diluted Earnings Per Share) (details)
Earnings Per Share (share Repurchase) (details)
Earnings Per Share (tables)
Fair Value Measurements (details)
Fair Value Measurements (notes)
Fair Value Measurements (schedule Of Financial Assets And Liabilities Measured At Fair Value On Recurring Basis) (details)
Fair Value Measurements (tables)
Financial Instruments
Financial Instruments (narrative) (details)
Financial Instruments (tables)
Financial Instruments Derivative (details)
Financing Receivables
Financing Receivables (narrative) (detail)
Financing Receivables (schedule Of Change In Allowance For Credit Losses On Financing Receivables) (detail)
Financing Receivables (tables)
Goodwill And Other Intangible Asset (changes In Carrying Amounts) (details)
Goodwill And Other Intangible Assets
Goodwill And Other Intangible Assets (amortization Expense) (details)
Goodwill And Other Intangible Assets (details)
Goodwill And Other Intangible Assets (tables)
Income Taxes (details)
Income Taxes (notes)
Income Taxes (unrecognized Tax Benefits) (details)
Inventories
Inventories (details)
Inventories (tables)
Investments In Unconsolidated Entities
Investments In Unconsolidated Entities (details)
Investments In Unconsolidated Entities (narrative) (details)
Investments In Unconsolidated Entities (tables)
Product Warranty Product Warranty (details)
Product Warranty Product Warranty (notes)
Product Warranty Product Warranty (tables)
Proposed Merger With Becton Dickinson (details)
Proposed Merger With Becton Dickinson Notes)
Reclassifications Out Of Accumulated Other Comprehensive Income (notes)
Reclassifications Out Of Accumulated Other Comprehensive Income (table) (details)
Reclassifications Out Of Accumulated Other Comprehensive Income (tables)
Restructuring And Related Activities (details)
Restructuring And Related Activities (notes)
Restructuring And Related Activities (schedule Of Segment Restructuring Charges) (details)
Restructuring And Related Activities (tables)
Schedule Of Debt (tables)
Segment Information
Segment Information (schedule Of Information About Reporting Segments) (details)
Segment Information (schedule Of Revenue And Net Property And Equipment By Geographic Area) (details)
Segment Information (schedule Of Revenue Information For Select Business Lines Within Each Of Segments) (details)
Segment Information (tables)

Material Contracts, Statements, Certifications & more

Carefusion Corp provided additional information to their SEC Filing as exhibits

Ticker: CFN
CIK: 1457543
Form Type: 10-Q Quarterly Report
Accession Number: 0001502823-15-000007
Submitted to the SEC: Fri Feb 06 2015 4:56:57 PM EST
Accepted by the SEC: Fri Feb 06 2015
Period: Wednesday, December 31, 2014
Industry: Surgical And Medical Instruments And Apparatus

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/cfn/0001502823-15-000007.htm